Mast cell degranulation - A mechanism for the anti-arrhythmic effect of endothelin-1?

British Journal of Pharmacology

Volumn 157, Issue 5, 2009, Pages 716-723

  Walsh, S K ^a,c   Kane, K A ^b   Wainwright, C L ^a  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c Irish Centre for Fetal and Neonatal Translational Research   (Ireland)

Author keywords

Arrhythmias; Endothelin 1; Mast cell degranulation; Myocardial ischaemia

Indexed keywords

COMPOUND 48-80; CROMOGLYCATE DISODIUM; ENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROCARDIOGRAPHY MONITORING; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; MALE; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; CELL DEGRANULATION; CROMOLYN SODIUM; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; ENDOTHELIN-1; HEART RATE; HISTAMINE RELEASE; INJECTIONS, INTRAVENOUS; MALE; MAST CELLS; MYOCARDIAL ISCHEMIA; P-METHOXY-N-METHYLPHENETHYLAMINE; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FIBRILLATION; VENTRICULAR PREMATURE COMPLEXES;

EID: 67651046165     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00222.x     Document Type: Article

References (40)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn (2008 revision). Br J Pharmacol 153 (Suppl. 2): S1-S209.
2. Boros M, Kaszaki J, Ordogh B, Nagy S (1999). Mast cell degranulation prior to ischemia decreases ischemia-reperfusion injury in the canine small intestine. Inflamm Res 48: 193-198. (Pubitemid 29192521)
3. Boros M, Szalay L, Kaszaki J (2002). Endothelin-1 induces mucosal mast cell degranulation and tissue injury via ETA receptors. Clin Sci (Land) 103 (Suppl. 48): 31S-34S. (Pubitemid 35007115)
4. Brunner F, du Toit EF, Opie LH (1992). Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol 24: 1291-1305.
5. Bugge E, Ytrehus K (1996). Endothelin-1 can reduce infarct size through protein kinase C and KATP channels in the isolated rat heart. Cardiovasc Res 32: 920-929. (Pubitemid 26342657)
6. Clark C, Foreman MI, Kane KA, McDonald FM, Parratt JR (1980). Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J. Pharmacol Methods 3: 357-368. (Pubitemid 10069345)
7. Crockett TR, Sharif I, Kane KA, Wainwright CL (2000). Sarafotoxin 6c protects against ischaemia-induced cardiac arrhythmias in vivo and in vitro in the rat. J Cardiovasc Pharmacol 36: 297-299. (Pubitemid 30815501)
8. Ehrenreich H, Burd PR, Rottem M, Hultner L, Hylton JB, Garfield M et al. (1992). Endothelins belong to the assortment of mast cellderived and mast cell-bound cytokines. New Biol 4: 147-156.
9. Estensen RD (1984). Eosinophilic myocarditis: a role for mast cells? Arch Pathol Lab Med 108: 358-359.
10. Foreman JC, Hallett MB, Mongar JL (1977). Site of action of the antiallergic drugs cromoglycate and doxantrazole (proceedings). Br J Pharmacol 59: 473P-474P.
11. Franzius D, Hoth M, Penner R (1994). Non-specific effects of calcium entry antagonists in mast cells. Pflugers Arch 428: 433-438. (Pubitemid 24321859)
12. Garjani A, Wainwright CL, Zeitlin IJ, Wilson C, Slee SJ (1995). Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischemic arrhythmias in anaesthetized rats. J Cardiovasc Pharmacol 25: 634-644.
13. Gray GA, Webb DJ (1996). The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol Ther 72: 109-148. (Pubitemid 26423301)
14. Hide EJ, Piper J, Thiemermann C (1995). Endothelin-1-induced reduction of myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol 116: 2597-2602.
15. Humphreys RA, Kane KA, Parratt JR (1998). Lack of involvement of mast cell degranulation in the anti-arrhythmic effect of preconditioning in rats. J Cardiovasc Pharmacol 31: 418-423.
16. Iliodromitis EK, Gaitanaki C, Lazou A, Aggeli IK, Gizas V, Bofilis E et al. (2006). Differential activation of mitogen-activated protein kinases in ischemic and nitroglycerin-induced preconditioning. Basic Res Cardiol 101: 327-335. (Pubitemid 43923389)
17. Jaggi AS, Singh M, Sharma A, Singh D, Singh N (2007). Cardioprotective effects of mast cell modulators in ischemia-reperfusion-induced injury in rats. Methods Find Exp Clin Pharmacol 29: 593-600. (Pubitemid 351183139)
18. 2+ channels in endothelin-1 function. Cell Signal 17: 911-916.
19. Kilgore KS, Tanhehco EJ, Naylor KB, Lucchesi BR (1999). Ex vivo reversal of heparin-mediated cardioprotection by heparinise after ischemia and reperfusion. J Pharmacol Exp Ther 290: 1041-1047.
20. Kubes P, Granger DN (1996). Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res 32: 699-708.
21. Lechleitner P, denser N, Mair J, Maier J, Artner-Dworzak E, Dienstl F et al. (1992). Endothelin-1 in patients with complicated and uncomplicated myocardial infarction. Clin Investig 70: 1070-1072.
22. Li Z, Niwa Y, Rokutan K, Nakaya Y (1999). Expression of endothelin-1 in macrophages and mast cells in hyperplastic human tonsils. FEBS Lett 457: 381-384. (Pubitemid 29414726)
23. Lim SY, Wainwright CL, Kennedy S, Kane KA (2007). Activation of protease activated receptor-2 induces delayed cardioprotection in anaesthetized mice. Cardiovasc Drugs Ther. DOI: 10.1007/s10557-007-6073-8.
24. Liu Y, Yamada H, Ochi J (1998). Immunocytochemical studies on endothelin in mast cells and macrophages in the rat gastrointestinal tract. Histochem Cell Biol 109: 301-307. (Pubitemid 28166146)
25. Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T et al. (2006). Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest 116: 1063-1070.
26. Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D et al. (2004). Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432: 512-516. (Pubitemid 39576533)
27. Messina A, Knight KR, Dowsing BJ, Zhang B, Phan LH, Hurley JV et al. (2000). Localization of inducible nitric oxide synthase to mast cells during ischemia/reperfusion injury of skeletal muscle. Lab Invest 80: 423-431. (Pubitemid 30167802)
28. 2+ changes and exocytosis of rat peritoneal mast cells. Arch Histol Cytol 63: 261-270.
29. Murray DB, Gardner JD, Brower GL, Janicki JS (2004). Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats. Am J Physiol Heart Circ Physiol 287: H2295-H2299.
30. Parikh V, Singh M (1997). Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 30: 149-156. (Pubitemid 27524513)
31. Parikh V, Singh M (1998). Cardiac mast cell stabilization and cardioprotective effect of ischemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 31: 779-785. (Pubitemid 28217600)
32. Peavy RD, Metcalfe DD (2008). Understanding the mechanisms of anaphylaxis. Curr Opin Allergy Clin Immunol 8: 310-315.
33. Pouchlev A, Youroukova Z, Kiprov D (1966). A study of changes in the number of mast cells in the human arterial wall during the stages of development of atherosclerosis. J Atheroscler Res 6: 342-351.
34. Sharif I, Kane KA, Wainwright CL (1998). Endothelin and ischaemic arrhythmias-antiarrhythrnic or arrhythmogenic? Cardiovasc Res 39: 625-632.
35. Singh M, Saini HK (2003). Resident cardiac mast cells and ischemiareperfusion injury. J Cardiovasc Pharmacol Ther 8: 135-148. (Pubitemid 36701938)
36. Triggiani M, Patella V, Staiano RI, Granata F, Marone G (2008). Allergy and the cardiovascular system. Clin Exp Immunol 153: 7-11.
37. Wainwright CL, McCabe C, Kane KA (2005). Endothelin and the ischaemic heart. Curr Vasc Pharmacol 3: 333-341.
38. Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM et al. (1988). The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 22: 447-455.
39. Wolff AA, Levi R (1988). Ventricular arrhythmias parallel cardiac histamine efflux after coronary artery occlusion in the dog. Agents Actions 25: 296-306.
40. Wolff AA, Levi R (1986). Histamine and cardiac arrhythmias. Circ Res 58: 1-16.